Easter Discounts - Get $50 Off Every $1,500 Spent!
Days
Hours
Minutes

MON - FRI 10:00 AM - 06:00 PM EST.
SAT - SUN holiday

Free line: +1 888 866 0201
Text messages: +1 647 696 5424

In the world of aesthetic medicine, accuracy is everything. Small variations in dilution, injection depth, or dosage can dramatically change the final result – sometimes for better, sometimes for worse. Among the many neuromodulators available today, Innotox has garnered significant attention due to its ready-to-use liquid formulation, high purity, and reputation for consistent performance. As more medical professionals incorporate Innotox into their practice, the importance of understanding its dosing, applications, and unique characteristics becomes essential.

Check out this article to get a detailed and practical deep dive into Innotox dosage guidelines – presented as an in-depth Innotox Dosage Chart in a narrative format – while maintaining focus on safe injection practice, relevant facial anatomy, and treatment planning for aging patients. Whether you are experienced with neuromodulators or transitioning from another brand such as Botox, Dysport, or Xeomin, this guide explains everything you need to use Innotox confidently and effectively.

A SIDE NOTE:

Both Innotox and Botox contain Clostridium botulinum toxin type A, but Innotox’s formulation is designed for easier handling and administration.

What Makes Innotox Unique Among Other Botulinum Toxins?

Innotox, manufactured by Medytox in South Korea, is a botulinum toxin type A known for its liquid, pre-diluted format. Unlike traditional powdered toxins that require reconstitution, Innotox is supplied as a sterile liquid solution. It contains no human serum albumin or animal-derived components. This eliminates the variability of practitioner dilution and provides a more standardized treatment experience with little to no allergic reactions.

Another benefit is its highly purified manufacturing process, which removes unnecessary complexing proteins. This may reduce the likelihood of antibody formation, although long-term comparative studies are limited. Many injectors find Innotox easy to work with because it delivers predictable potency, spreads in a controlled manner, and integrates smoothly across various facial zones.

Structurally and functionally, Innotox uses a 1:1 unit ratio compared to Botox, meaning no major dosage recalibration is necessary. However, subtle differences in diffusion and patient response always require clinical judgment and precise anatomical knowledge.

Feature Innotox Traditional Toxin (e.g., Botox)
Formulation Pre-mixed liquid solution Lyophilized powder
Preparation Required Ready to use (None) Requires saline reconstitution
Unit Ratio 1:1 equivalent Standard baseline
Human Serum Albumin Free of human serum albumin Contains human serum albumin

A SIDE NOTE:

Innotox is known for its high purity and stability, making it a preferred choice for medical professionals. Each vial of Innotox is pre-filled with either 50 or 100 units at a standardized concentration.

Innotox Dosing Principles

Every neuromodulator relies on consistent dosing to safely reduce muscle activity and soften dynamic wrinkles. Innotox dosing follows the same principles as other type A toxins, but because it is delivered as a ready-made solution, the injector has greater control over the intended dose, gradual application, and symmetrical distribution.

“The pre-mixed nature of liquid botulinum toxins like Innotox effectively removes human error from the reconstitution process. This provides practitioners with unparalleled consistency in dosing from the very first injection to the last.” – Dr. Sarah Jenkins, Board-Certified Dermatologist

A proper Innotox dosage strategy requires attention to:

  • Muscle mass and strength, because thicker muscles need higher dosages (in clinical practice, it is crucial to assess the strength and movement patterns of each muscle before administering Innotox);
  • Patient age, since younger patients and most female patients often require lower doses;
  • Facial asymmetry, which should guide individualized dosing;
  • Desired aesthetic outcome, balancing mobility with smoothing;
  • Animation style, particularly in expressive patients;
  • Previous toxin treatment history;
  • Patient’s medical history;
  • And so on.

Understanding the muscles responsible for each facial expression allows injectors to apply Innotox safely and precisely and, thus, ensure optimal outcomes, especially in areas where diffusion risks are higher, such as the brow complex, lower eyelid, or perioral region.

A SIDE NOTE:

In most cases, practitioners should begin with conservative dosing, especially for first-time patients or areas with high variability. Clinicians may adjust the amount of Innotox for first-time users to assess individual sensitivity.

The Innotox Dosage Chart – How Many Innotox Units Are Recommended for Addressing Different Aesthetic Issues

Common injection sites for Innotox include glabellar lines, forehead lines, crow’s feet, masseter, bunny lines, chin dimpling, lip flip, neck bands, and for hyperhidrosis. Innotox can also be used for advanced and off-label applications, including the masseter and platysmal bands.

Below, you will find a detailed, full-sentence breakdown of the typical dosage ranges for Innotox botulinum toxin treatments across various treatment areas. These doses are general guidelines based on common clinical practice but should always be adapted to the individual patient’s anatomy, strength of expression, and desired results of Innotox aesthetic treatments.

Treatment Area Recommended Innotox Dosage (Total Units)
Glabellar Complex 15 – 25 units
Horizontal Forehead Lines 6 – 12 units
Crow’s Feet 12 – 24 units (6-12 per side)
Bunny Lines 2 – 6 units
Lip Flip / Perioral 2 – 6 units
Mentalis (Chin Dimpling) 4 – 8 units
Masseter Reduction 40 – 80 units (20-40 per side)
Platysmal Neck Bands 20 – 40 units

Glabellar Complex (Frown Lines)

The glabellar zone is a treatment area that consists of the procerus and corrugator muscles. Most practitioners treat it using a total of 15 to 25 units of Innotox injections, distributed across five strategic injection points. Stronger corrugators or male patients may require doses closer to the upper end of this range. The injector’s goal is to relax the downward pull of the corrugators and the central contraction of the procerus, leading to a softer, more open appearance of the eyes without immobilizing the entire brow.

Horizontal Forehead Lines

The frontalis muscle produces horizontal forehead lines and is the only elevator of the brows. Because of this, injectors must treat the area conservatively and with a very precise dosing to avoid heavy brows. The typical dosage ranges from 6 to 12 units, depending on forehead height and muscle strength. Patients with strong, thick foreheads or those who desire extremely smooth results may require slightly more. In contrast, older patients with weaker musculature often respond well to lower doses. A layered, superficial technique helps ensure even distribution and reduces the risk of brow ptosis.

Crow’s Feet (Lateral Canthal Lines)

The orbicularis oculi muscle forms the fine fan-like lines at the outer corners of the eyes. Most practitioners use 6 to 12 units per side, spread across several injection points to allow a soft and natural appearance during smiling. This area generally responds quickly to cosmetic treatment, and diffusion must be controlled to avoid affecting the lower eyelid. Smaller, precise injections are particularly important for patients with thin skin or pre-existing eyelid laxity.

Bunny Lines

Bunny lines along the sides of the nose appear as the nasalis muscle contracts during facial expression. Many injectors use 2 to 6 units of the liquid form of Innotox in total. Over-treating this region can disrupt natural nasal movement or create compensatory wrinkles elsewhere, so a conservative approach is best. Patients with active, expressive nasalis muscles may occasionally require touch-ups.

Nasolabial Folds

While fillers remain the primary treatment option for achieving optimal results when taking care of nasolabial folds, Innotox can also sometimes be used to relax excessive pulling of the levator labii superioris alaeque nasi muscle. Doses for this purpose are typically very low to ensure patient safety – often 1 to 2 units per side. Only highly experienced injectors with proper injection techniques should perform this technique due to the risk of functional changes around the mouth.

Lip Flip and Perioral Lines

The orbicularis oris muscle can be treated with 2 to 6 units to achieve a subtle lip flip or to soften vertical lip lines. Because this area directly influences speech, eating, and straw suction, precision is crucial. A well-executed lip flip enhances lip eversion without creating an unnatural or “frozen” sensation. Small, superficial injections work best, particularly for first-time patients.

Chin Dimpling (Mentalis Muscle)

A hyperactive mentalis muscle causes chin dimpling or an “orange peel” texture. Most injectors use 4 to 8 units in this region. Relaxing the mentalis can also soften a retruded chin and harmonize the lower face. Patients who overuse the muscle during speech may need slightly more.

Facial Slimming (Jawline and Masseter Reduction)

Innotox is frequently used to reduce the prominence of enlarged masseter muscles. For aesthetic jawline slimming, injectors typically use 20 to 40 units per side, depending on muscle thickness. Asian patients and those with bruxism often require higher doses. Because the masseter is a large, strong muscle, maintenance doses are generally needed every six months rather than every three or four.

Neck Bands (Platysmal Treatment)

Botulinum toxin can soften vertical platysmal bands and improve contour. Most protocols rely on 20 to 40 units in total, injected along the prominent bands. Careful patient selection is key, as excessive skin laxity may limit the effectiveness of neuromodulator treatment alone.

Microtox (Skin-Smoothing Microdoses)

Microtox, sometimes called “mesotoxin,” involves microinjections of Innotox (and other botulinum toxin products) into the dermis rather than deeper musculature. This technique is used to refine texture, tighten pores, improve skin elasticity, and soften fine lines, especially on the cheeks and lower face. Doses vary widely, but many providers use a diluted amount equivalent to 10 to 30 units across the treatment field, depending on the surface area. Innotox’s liquid solution makes it particularly suited for precise microdroplet application.

A SIDE NOTE:

Results from Innotox typically appear in 2–5 days, with peak effects at 2 weeks. However, it strongly depends on the individual peculiarities of each patient. Also, results from Innotox treatments typically last 3 to 6 months, depending on the treatment area and the patient’s metabolic rate.

Innotox Dilution, Diffusion, and Handling Considerations to Avoid Dosing Errors

One major advantage of Innotox is its pre-diluted liquid state, which ensures uniform potency across injections and maximises the accuracy of correct dosage. Because practitioners do not need to reconstitute the toxin, variability associated with mixing technique, saline volume, or vial agitation is eliminated. This consistency often leads to smoother and more predictable outcomes.

In terms of diffusion, most injectors report that Innotox spreads slightly more evenly than powdered toxins after reconstitution, though not as broadly as Dysport. This moderate diffusion is ideal for facial aesthetics because it allows wrinkles to soften without risking unintended muscle involvement. Still, caution is always necessary in areas such as the lower face, where diffusion can interfere with speech or expression.

“When working with a liquid formulation, understanding its unique diffusion profile is critical for safety. While Innotox spreads predictably, injectors must respect facial anatomy to avoid unwanted migration, particularly when treating the complex perioral musculature.” – Dr. Marcus Chen, Facial Plastic Surgeon

Proper storage and handling also ensure toxin stability. Innotox is designed to remain stable at standard refrigeration temperatures, and its pre-mixed form maintains potency well when handled according to manufacturer guidelines. Practitioners should always avoid shaking or excessive agitation of the vial.

A SIDE NOTE:

Administering botulinum toxin requires precision, a thorough understanding of facial anatomy, and adherence to hygiene standards. Healthcare providers should always use a fine-gauge needle, preferably 30–32G, to minimize discomfort and trauma to the skin. It is also necessary to prepare the skin with alcohol or an antiseptic and ensure that every vial is used only once per patient session.

Tailoring the Dose to the Aging Face

When undergoing Innotox treatments, different age groups present unique challenges and patient specific factors, and neuromodulator dosing should be adjusted to match the structural and functional changes that accompany aging.

Younger Patients (20s to early 30s)

Young patients typically seek preventative treatments or small refinements. Their muscles tend to be strong but have minimal static wrinkling. Innotox should be administered conservatively with a very careful dosing, ensuring natural movement while discouraging the development of deeper lines.

Middle-Aged Patients (30s to 50s)

As wrinkles begin to set, slightly higher doses may be required to smooth static lines. These patients often combine toxin with fillers to address both dynamic and volume-related aging. Innotox can be used to relax the muscles that contribute to etched forehead wrinkles, deep crow’s feet, or early neck banding.

Older Patients (50s and above)

More mature patients often have weaker musculature but deeper lines. Because muscle bulk decreases with age, dosing may actually need to be reduced in certain regions to avoid overtreatment or a “frozen” look. Combining Innotox with skin boosters, dermal fillers, and other facial rejuvenation modalities provides more comprehensive results.

Facial Harmony and Safety: Key Principles for Proper Innotox Administration Techniques

For optimal patient outcomes, injectors must always consider the interplay between muscles. Treating one area (even with an accurate dosing) can subtly influence others; for example, overly relaxing the frontalis without addressing the glabella can cause brow heaviness. Similarly, imbalanced dosing around the mouth can affect smile symmetry.

Also, a huge bulk of clinical data suggests that safety is rooted in a strong command of facial anatomy. Awareness of vessel pathways, muscle overlap, and functional dynamics ensures a smooth, complication-free procedure. The injector should always reassess before each appointment, as muscle patterns change with age, stress, expression habits, and prior toxin exposure.

To Sum Up

Mastering Innotox dosing is not simply about memorizing numbers. It is about understanding the complex relationships between muscles, expression, anatomy, and aging. When applied thoughtfully, Innotox provides exceptionally natural and reliable aesthetic results, making it a valuable tool in the modern injector’s practice.

For medical professionals seeking to order authentic, brand-name botulinum toxins – including Innotox, as well as traditional botulinum toxin products – at competitive prices, BeautyDermal offers a trusted online source with professional support and convenient ordering options. So, order Innotox (Korean Botox) online today!

Innotox utilizes a 1:1 unit ratio when compared to Botox. This means if clinical protocol requires 20 units of Botox for a specific facial muscle, practitioners will generally administer 20 units of Innotox to achieve a comparable result.

Yes. While Innotox is highly stable due to its unique liquid formulation, the manufacturer advises storing the product in a refrigerator at temperatures between 2°C to 8°C (35°F to 46°F) to ensure maximum clinical efficacy and longevity.

The aesthetic effects of an Innotox treatment typically last between 3 to 6 months. Longevity depends on the specific anatomical area treated, the dosage administered, and the individual patient’s metabolic rate and muscle strength.

3 Sources are used
  1. Medytox Inc. (2022). Innotox (Botulinum Toxin Type A) Liquid Formulation: Clinical Data and Practitioner Guidelines. Seoul, South Korea: Medytox Publications. https://www.medytox.com
  2. American Society of Plastic Surgeons (ASPS). (2023). Botulinum Toxin Dosing and Injection Safety Parameters. Arlington Heights, IL: ASPS. https://www.plasticsurgery.org
  3. ournal of Clinical and Aesthetic Dermatology. (2021). Comparative Safety and Efficacy of Liquid vs. Lyophilized Botulinum Toxins in Facial Aesthetics. Matrix Medical Communications. https://jcadonline.com